NCT01016639View on ClinicalTrials.gov

Study of Capecitabine and Oxaliplatin in Combination With Radiotherapy in Patients With Unresectable Gastro-Intestinal Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

106

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2009

Conditions
Stomach CancerGall Bladder CancerBile Ductus CancerPancreas CancerColorectal Cancer
Interventions
OTHER

oxaliplatin, capecitabine, radiotherapy

Trial Locations (5)

Unknown

Centralsjukhuset, Dept of Oncology, Karlstad

University Hospital Lund, Lund

University Hospital Malmö, Dept of Oncology, Malmo

Karolinska University Hospital, Stockholm

Akademiska Sjukhuset, Uppsala

Sponsors

Collaborators (1)

Sanofi-Synthelabo
All Listed Sponsors
collaborator

Roche Pharma AG

INDUSTRY

collaborator

Sanofi-Synthelabo

INDUSTRY

lead

Lund University Hospital

OTHER

NCT01016639 - Study of Capecitabine and Oxaliplatin in Combination With Radiotherapy in Patients With Unresectable Gastro-Intestinal Cancer | Biotech Hunter | Biotech Hunter